A detailed history of Peavine Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Peavine Capital, LLC holds 2,550 shares of JNJ stock, worth $373,345. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,550
Previous 2,550 -0.0%
Holding current value
$373,345
Previous $372,000 11.02%
% of portfolio
0.1%
Previous 0.09%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$168.19 - $186.01 $67,276 - $74,404
-400 Reduced 13.56%
2,550 $453,000
Q1 2022

Apr 22, 2022

SELL
$158.14 - $179.59 $117,023 - $132,896
-740 Reduced 20.05%
2,950 $523,000
Q1 2020

Apr 29, 2020

SELL
$111.14 - $153.99 $22,228 - $30,798
-200 Reduced 5.14%
3,690 $484,000
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $122,840 - $147,840
-1,000 Reduced 20.45%
3,890 $631,000
Q2 2018

Jul 16, 2018

BUY
$119.4 - $131.76 $304,470 - $335,988
2,550 Added 108.97%
4,890 $593,000
Q3 2017

Oct 13, 2017

BUY
$129.47 - $135.38 $302,959 - $316,789
2,340
2,340 $304,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Peavine Capital, LLC Portfolio

Follow Peavine Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peavine Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peavine Capital, LLC with notifications on news.